"Preferred Physicians Medical RRG","PNC QS","2024 06 30" Annual Statutory Statement - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Reinsurance
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Reinsurance RSS Get our newsletter
Order Prints
August 16, 2024 Reinsurance
Share
Share
Post
Email

"Preferred Physicians Medical RRG","PNC QS","2024 06 30" Annual Statutory Statement

U.S. Markets via PUBT

STATEMENT AS OF JUNE 30, 2024 OF THE Preferred Physicians Medical Risk Retention Group, a Mutual Insurance

Company

ASSETS

Current Statement Date

4

1

2

3

December 31

Net Admitted Assets

Prior Year Net

Assets

Nonadmitted Assets

(Cols. 1 - 2)

Admitted Assets

1. Bonds

11,254,818

11,254,818

11,273,336

  1. Stocks:
    1. Preferred stocks
    2. Common stocks
  2. Mortgage loans on real estate:
    1. First liens
    2. Other than first liens
  3. Real estate:
    1. Properties occupied by the company (less

$

0

encumbrances)

4.2 Properties held for the production of income

(less $

0 encumbrances)

4.3 Properties held for sale (less

$

0

encumbrances)

5.

Cash ($

(310,535) ),

cash equivalents ($

2,898,353

)

and short-term investments ($

0

)

2,587,818

2,587,818

5,727,736

6.

Contract loans (including $

0

premium notes)

  1. Derivatives
  2. Other invested assets
  3. Receivables for securities
  4. Securities lending reinvested collateral assets
  5. Aggregate write-ins for invested assets

12.

Subtotals, cash and invested assets (Lines 1 to 11)

13,842,636

13,842,636

17,001,072

13.

Title plants less $

0 charged off (for Title insurers

only)

14.

Investment income due and accrued

12,381

12,381

30,450

15.

Premiums and considerations:

15.1 Uncollected premiums and agents' balances in the course of

collection

6,709,977

6,709,977

10,996,867

15.2 Deferred premiums, agents' balances and installments booked but

deferred and not yet due (including $

0 earned

but unbilled premiums)

15.3 Accrued retrospective premiums

($

0 ) and

contracts subject to redetermination ($

0 )

16.

Reinsurance:

16.1 Amounts recoverable from reinsurers

336,401

336,401

303,991

  1. Funds held by or deposited with reinsured companies
  2. Other amounts receivable under reinsurance contracts

17. Amounts receivable relating to uninsured plans

  1. Current federal and foreign income tax recoverable and interest thereon
  2. Net deferred tax asset
  1. Guaranty funds receivable or on deposit
  2. Electronic data processing equipment and software
  3. Furniture and equipment, including health care delivery assets

($

0 )

  1. Net adjustment in assets and liabilities due to foreign exchange rates
  2. Receivables from parent, subsidiaries and affiliates

24. Health care ($

0 ) and other amounts receivable

  1. Aggregate write-ins for other-than-invested assets
  2. Total assets excluding Separate Accounts, Segregated Accounts and

Protected Cell Accounts (Lines 12 to 25)

20,901,395

20,901,395

28,332,380

27.

From Separate Accounts, Segregated Accounts and Protected

Cell Accounts

28.

Total (Lines 26 and 27)

20,901,395

20,901,395

28,332,380

DETAILS OF WRITE-INS

1101.

1102.

1103.

1198. Summary of remaining write-ins for Line 11 from overflow page

1199. Totals (Lines 1101 through 1103 plus 1198) (Line 11 above)

2501.

2502.

2503.

2598. Summary of remaining write-ins for Line 25 from overflow page

2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)

2

STATEMENT AS OF JUNE 30, 2024 OF THE Preferred Physicians Medical Risk Retention Group, a Mutual Insurance

Company

LIABILITIES, SURPLUS AND OTHER FUNDS

1

2

Current

December 31,

Statement Date

Prior Year

1.

Losses (current accident year $

0

)

2.

Reinsurance payable on paid losses and loss adjustment expenses

3.

Loss adjustment expenses

3,200,561

3,200,561

4.

Commissions payable, contingent commissions and other similar charges

5.

Other expenses (excluding taxes, licenses and fees)

629,576

1,566,401

6.

Taxes, licenses and fees (excluding federal and foreign income taxes)

272,018

407,100

7.1Current federal and foreign income taxes (including $

0

on realized capital gains (losses))

7.2 Net deferred tax liability

8.

Borrowed money $

0 and interest thereon $

0

9.

Unearned premiums (after deducting unearned premiums for ceded reinsurance of $

21,410,558 and

including warranty reserves of $

0 and accrued accident and health experience rating refunds

including $

0 for medical loss ratio rebate per the Public Health Service Act)

10.

Advance premium

348,101

737,775

11. Dividends declared and unpaid:

  1. Stockholders
  2. Policyholders

12.

Ceded reinsurance premiums payable (net of ceding commissions)

10,176,966

16,085,148

13.

Funds held by company under reinsurance treaties

14.

Amounts withheld or retained by company for account of others

195,452

258,974

15.

Remittances and items not allocated

16.

Provision for reinsurance (including $

0 certified)

  1. Net adjustments in assets and liabilities due to foreign exchange rates
  2. Drafts outstanding

19. Payable to parent, subsidiaries and affiliates

1,078,721

1,076,421

  1. Derivatives
  2. Payable for securities
  3. Payable for securities lending
  4. Liability for amounts held under uninsured plans

24.

Capital notes $

0 and interest thereon $

0

25.

Aggregate write-ins for liabilities

26.

Total liabilities excluding protected cell liabilities (Lines 1 through 25)

15,901,395

23,332,380

27.

Protected cell liabilities

28.

Total liabilities (Lines 26 and 27)

15,901,395

23,332,380

  1. Aggregate write-ins for special surplus funds
  2. Common capital stock
  3. Preferred capital stock
  4. Aggregate write-ins for other than special surplus funds

33. Surplus notes

5,000,000

5,000,000

  1. Gross paid in and contributed surplus
  2. Unassigned funds (surplus)
  3. Less treasury stock, at cost:

36.1

0

shares common (value included in Line 30

$

0

)

36.2

0

shares preferred (value included in Line 31

$

0

)

37.

Surplus as regards policyholders (Lines 29 to 35, less 36)

5,000,000

5,000,000

38.

Totals (Page 2, Line 28, Col. 3)

20,901,395

28,332,380

DETAILS OF WRITE-INS

2501.

2502.

2503.

2598. Summary of remaining write-ins for Line 25 from overflow page

2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)

2901.

2902.

2903.

2998. Summary of remaining write-ins for Line 29 from overflow page

2999. Totals (Lines 2901 through 2903 plus 2998) (Line 29 above)

3201.

3202.

3203.

3298. Summary of remaining write-ins for Line 32 from overflow page

3299. Totals (Lines 3201 through 3203 plus 3298) (Line 32 above)

3

STATEMENT AS OF JUNE 30, 2024 OF THE Preferred Physicians Medical Risk Retention Group, a Mutual Insurance

Company

STATEMENT OF INCOME

1

2

3

Current Year

Prior Year

Prior Year Ended

to Date

to Date

December 31

1.

Premiums earned:

UNDERWRITING INCOME

1.1

Direct (written $

11,617,236

)

16,050,968

15,355,186

32,821,947

1.2

Assumed (written $

0 )

1.3

Ceded (written $

11,617,236

)

16,050,968

15,355,186

32,821,947

1.4

Net (written $

0

)

2.

DEDUCTIONS:

Losses incurred (current accident year $

6,585,690 ):

2.1 Direct

5,896,995

3,647,752

4,138,568

2.2 Assumed

2.3 Ceded

5,896,995

3,647,752

4,138,568

3.

2.4 Net

Loss adjustment expenses incurred

1,102,994

1,105,573

2,037,396

4.

Other underwriting expenses incurred

(822,261)

(811,508)

(1,472,924)

5.

Aggregate write-ins for underwriting deductions

6.

Total underwriting deductions (Lines 2 through 5)

280,733

294,065

564,472

7.

Net income of protected cells

8.

Net underwriting gain (loss) (Line 1 minus Line 6 + Line 7)

(280,733)

(294,065)

(564,472)

9.

Net investment income earned

INVESTMENT INCOME

215,135

290,016

508,672

10.

Net realized capital gains (losses) less capital gains tax of $

0

11.

Net investment gain (loss) (Lines 9 + 10)

215,135

290,016

508,672

12.

OTHER INCOME

Net gain or (loss) from agents' or premium balances charged off

13.

(amount recovered $

0

amount charged off $

0 )

Finance and service charges not included in premiums

14.

Aggregate write-ins for miscellaneous income

65,598

74,608

15.

Total other income (Lines 12 through 14)

65,598

74,608

16.

Net income before dividends to policyholders, after capital gains tax and before all other federal

and foreign income taxes (Lines 8 + 11 + 15)

(4,049)

18,808

  1. Dividends to policyholders
  2. Net income, after dividends to policyholders, after capital gains tax and before all other federal

19.

and foreign income taxes (Line 16 minus Line 17)

(4,049)

18,808

Federal and foreign income taxes incurred

(4,049)

18,808

20.

Net income (Line 18 minus Line 19)(to Line 22)

21.

CAPITAL AND SURPLUS ACCOUNT

Surplus as regards policyholders, December 31 prior year

5,000,000

5,000,000

5,000,000

  1. Net income (from Line 20)
  2. Net transfers (to) from Protected Cell accounts
  3. Change in net unrealized capital gains or (losses) less capital gains tax of

$0

  1. Change in net unrealized foreign exchange capital gain (loss)
  2. Change in net deferred income tax
  3. Change in nonadmitted assets
  4. Change in provision for reinsurance
  5. Change in surplus notes
  6. Surplus (contributed to) withdrawn from protected cells
  7. Cumulative effect of changes in accounting principles
  8. Capital changes:
    1. Paid in
    2. Transferred from surplus (Stock Dividend)
    3. Transferred to surplus
  9. Surplus adjustments:
    1. Paid in
    2. Transferred to capital (Stock Dividend)
    3. Transferred from capital
  10. Net remittances from or (to) Home Office
  11. Dividends to stockholders
  12. Change in treasury stock
  13. Aggregate write-ins for gains and losses in surplus
  14. Change in surplus as regards policyholders (Lines 22 through 37)

39.

Surplus as regards policyholders, as of statement date (Lines 21 plus 38)

5,000,000

5,000,000

5,000,000

0501.

DETAILS OF WRITE-INS

0502.

0503.

0598.

Summary of remaining write-ins for Line 5 from overflow page

0599.

TOTALS (Lines 0501 through 0503 plus 0598) (Line 5 above)

1401.

MIscellaneous Income

65,598

74,608

1402.

1403.

1498.

Summary of remaining write-ins for Line 14 from overflow page

1499.

TOTALS (Lines 1401 through 1403 plus 1498) (Line 14 above)

65,598

74,608

3701.

3702.

3703.

3798.

Summary of remaining write-ins for Line 37 from overflow page

3799.

TOTALS (Lines 3701 through 3703 plus 3798) (Line 37 above)

4

STATEMENT AS OF JUNE 30, 2024 OF THE Preferred Physicians Medical Risk Retention Group, a Mutual Insurance

Company

CASH FLOW

1

2

3

Current Year

Prior Year

Prior Year Ended

To Date

To Date

December 31

1.

Cash from Operations

Premiums collected net of reinsurance

(2,010,966)

(2,371,549)

283,606

2.

Net investment income

239,805

297,204

578,180

3.

Miscellaneous income

65,598

74,608

4.

Total (Lines 1 to 3)

(1,705,563)

(2,074,345)

936,394

5.

Benefit and loss related payments

32,410

1,796,237

(269,384)

6.

Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts

7.

Commissions, expenses paid and aggregate write-ins for deductions

1,413,860

1,248,394

990,759

8.

Dividends paid to policyholders

9.

Federal and foreign income taxes paid (recovered) net of $

0 tax on capital

10.

gains (losses)

(81,009)

Total (Lines 5 through 9)

1,446,270

3,044,631

640,366

11.

Net cash from operations (Line 4 minus Line 10)

(3,151,833)

(5,118,976)

296,028

12.

Cash from Investments

Proceeds from investments sold, matured or repaid:

12.1

Bonds

850,000

12.2

Stocks

12.3

Mortgage loans

12.4

Real estate

12.5

Other invested assets

12.6

Net gains or (losses) on cash, cash equivalents and short-term investments

12.7

Miscellaneous proceeds

13.

12.8

Total investment proceeds (Lines 12.1 to 12.7)

850,000

Cost of investments acquired (long-term only):

13.1

Bonds

838,084

13.2

Stocks

13.3

Mortgage loans

13.4

Real estate

13.5

Other invested assets

13.6

Miscellaneous applications

14.

13.7

Total investments acquired (Lines 13.1 to 13.6)

838,084

Net increase/(decrease) in contract loans and premium notes

15.

Net cash from investments (Line 12.8 minus Line 13.7 and Line 14)

11,916

16.

Cash from Financing and Miscellaneous Sources

Cash provided (applied):

16.1

Surplus notes, capital notes

16.2

Capital and paid in surplus, less treasury stock

16.3

Borrowed funds

16.4

Net deposits on deposit-type contracts and other insurance liabilities

16.5

Dividends to stockholders

16.6

Other cash provided (applied)

17.

Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5

plus Line 16.6)

18.

RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)

(3,139,917)

(5,118,976)

296,028

19.

Cash, cash equivalents and short-term investments:

19.1

Beginning of year

5,727,735

5,431,707

5,431,707

19.2

End of period (Line 18 plus Line 19.1)

2,587,818

312,731

5,727,735

5

6WDWHPHQWDVRI-XQHRIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY

127(672),1$1&,$/67$7(0(176

Note 1 - Summary of Significant Accounting Policies and Going Concern

  1. Accounting practices
    The financial statements of Preferred Physicians Medical Risk Retention Group, a Mutual Insurance Company (the Company) are presented on the basis of accounting practices prescribed or permitted by the Missouri Department of Commerce and Insurance.
    The Missouri Department of Insurance recognizes only statutory accounting practices prescribed or permitted by the State of Missouri for determining and reporting the financial condition and results of operations of an insurance company, and for determining its solvency under the Missouri Insurance Law. The National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures manual, as amended from time to time, (NAIC SAP) has been adopted as a component of prescribed or permitted practices by the State of Missouri. The Director of Insurance has the right to permit other specific practices that deviate from prescribed practices. There was no difference between NAIC SAP and state permitted practices for either net income or statutory surplus for the quarter ended June 30, 2024.
    A reconciliation of the Company's net income and capital and surplus between NAIC SAP and practices prescribed and permitted by State of Missouri is shown below:

Year-to-date period ended

NET INCOME

SSAP

F/S

F/S

June 30,

December 31,

#

Page

Line #

2024

2023

(1)

State basis (Page 4, Line 20, Columns 1 & 3)

XXX

XXX

XXX

$

-

$

-

(2)

State Prescribed Practices that are an increase/

-

-

(decrease) from NAIC SAP:

(3)

State Permitted Practices that are an increase/

-

-

(decrease) from NAIC SAP:

(4)

NAIC SAP (1-2-3=4)

XXX

XXX

XXX

$

-

$

-

SURPLUS

(5)

State basis (Page 3, Line 37, Columns 1 & 2)

XXX

XXX

XXX

$

5,000,000

$

5,000,000

(6)

State Prescribed Practices that are an increase/

-

-

(decrease) from NAIC SAP:

(7)

State Permitted Practices that are an increase/

-

-

(decrease) from NAIC SAP:

(8)

NAIC SAP (5-6-7=8)

XXX

XXX

XXX

$

5,000,000

$

5,000,000

The term "none" or "no significant change" is used in the following notes to indicate that the Company does not have any items requiring disclosure under the respective note.

  1. Use of estimates in the preparation of the financial statements - No significant change.
  2. Accounting policy
    1. - (5) No significant change.
    1. Loan-backedsecurities are reported at amortized cost provided that the SVO's designation is 1 or 2. If the SVO's designation is 3 or greater, the security is reported at the lower of amortized cost or fair value. The Company uses the prospective method to make valuation adjustments when necessary.
    2. - (13) No significant change.
  1. Going Concern
    Management has concluded that there is no doubt regarding the Company's ability to continue as a going concern.

Note 2 - Accounting Changes and Corrections of Errors- None.

Note 3 - Business Combinations and Goodwill- None.

Note 4 - Discontinued Operations- None.

Note 5 - Investments

  1. Mortgage loans, including mezzanine real estate loans - None.
  2. Debt restructuring - None.
  3. Reverse mortgages - None.

6

6WDWHPHQWDVRI-XQHRIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY

127(672),1$1&,$/67$7(0(176

  1. Loan-backedsecurities - None.
  2. Dollar repurchase agreements and/or securities lending transactions - None.
  3. Repurchase agreements transactions accounted for as secured borrowing - None.
  4. Reverse repurchase agreements transactions accounted for as secured borrowing - None.
  5. Repurchase agreements transactions accounted for as a sale - None.
  6. Reverse repurchase agreements transactions accounted for as a sale - None.
  7. Real estate - None.
  8. Low-incomehousing tax credits (LIHTC) - None.
  9. Restricted assets - No significant change.
    1. Restricted assets (including pledged)

Gross (Admitted & Nonadmitted) Restricted

Current Year

Current Year

Percentage

1

2

3

4

5

6

7

8

9

10

11

G/A

Total

Protected

Cell

Admitted

Total

Supporting

Protected

Account

Total

Gross

Protected

Cell

Assets

Increase/

Total

Restricted

Restricted Asset Category

General

Cell

Account

Supporting

Total

Total From

Admitted

Restricted

to Total

Account

Account

Restricted

G/A

(Decrease)

Nonadmitted

Restricted

to Total

Admitted

(G/A)

Activity (a)

Assets

Activity (b)

(1 plus 3)

Prior Year

(5 minus 6)

Restricted

(5 minus 8)

Assets (c)

Assets (d)

a. Subject to contractual

obligation for which

liability is not shown

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

-

-

b. Collateral held under

security lending

agreements

-

-

-

-

-

-

-

-

$

-

-

-

c. Subject to repurchase

agreements

-

-

-

-

-

-

-

-

$

-

-

-

d. Subject to reverse

repurchase agreements

-

-

-

-

-

-

-

-

$

-

-

-

e. Subject to dollar

repurchase agreements

-

-

-

-

-

-

-

-

$

-

-

-

f. Subject to dollar

-

-

-

-

-

-

-

-

$

-

-

-

reverse repurchase

agreements

g. Placed under option

contracts

-

-

-

-

-

-

-

-

$

-

-

-

h. Letter stock or

securities restricted as

to sale - excluding FHLB

capital stock

-

-

-

-

-

-

-

-

$

-

-

-

i. FHLB capital stock

-

-

-

-

-

-

-

-

$

-

-

-

j. On deposit with states

834,965

-

-

-

834,965

850,003

(15,038)

-

$

834,965

4.0 %

4.0 %

k. On deposit with other

regulatory bodies

-

-

-

-

-

-

-

-

$

-

-

-

l. Pledged as collateral

to FHLB (including

assets backing funding

agreements)

-

-

-

-

-

-

-

-

$

-

-

-

m. Pledged as collateral

not captured in other

categories

-

-

-

-

-

-

-

-

$

-

-

-

n. Other restricted

assets

-

-

-

-

-

-

-

-

$

-

-

-

o. Total Restricted

Assets

$

834,965

$

-

$

-

$

-

$

834,965

$

850,003

$

(15,038)

$

-

$

834,965

4.0 %

4.0 %

  1. Subset of column 1
  2. Subset of column 3
  3. Column 5 divided by Asset Page, Column 1 Line 28
  4. Column 9 divided by Asset Page, Column 3, Line 28
    1. Detail of assets pledged as collateral not captured in other categories - None.
    2. Detail of other restricted assets - None.
    3. Collateral received and reflected as assets within the reporting entity's financial statements - None.
  1. Working capital finance investments - None.
  2. Offsetting and netting of assets and liabilities - None.
  3. 5GI Securities - None.
  4. Short sales - None.
  5. Prepayment penalty and acceleration fees - None.

6.1

6WDWHPHQWDVRI-XQHRIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY

127(672),1$1&,$/67$7(0(176

R. Reporting entity's share of cash pool by asset type - None.

Note 6 - Joint Ventures, Partnerships and Limited Liability Companies

  1. Detail for those greater than 10% of admitted assets - None.
  2. Write-downsfor impairments - None.

Note 7 - Investment Income

  1. Accrued investment income excluded from surplus - None.
  2. Amounts nonadmitted - None.
  3. The gross, nonadmitted and admitted amounts for interest income due and accrued

Interest Income Due and Accrued

Amount

1.

Gross

$

12,381

2.

Nonadmitted

$

-

3.

Admitted

$

12,381 .

  1. The aggregate deferred interest - None.
  2. The cumulative amounts of paid-in-kind (PIK) interest included in the current principal balance - None.

Note 8 - Derivative Instruments- None.

6.2

6WDWHPHQWDVRI-XQHRIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY

127(672),1$1&,$/67$7(0(176

Note 9 - Income Taxes

A. The components of the net deferred tax asset/(liability) at June 30 are as follows:

1.

Change between years

6/30/2024

12/31/2023

Change

by tax character

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(Col 1+2)

(Col 4+5)

(Col 1-4)

(Col 2-5)

(Col 7+8)

Ordinary

Capital

Total

Ordinary

Capital

Total

Ordinary

Capital

Total

(a)

Gross Deferred Tax Assets

$

82,078

$

-

$

82,078

$

86,269

$

-

$

86,269

$

(4,191)

$

-

$

(4,191)

(b)

Statutory Valuation Allowance

79,343

-

79,343

82,692

-

82,692

(3,349)

-

(3,349)

Adjustments

(c)

Adjusted Gross Deferred Tax

2,735

-

2,735

3,577

-

3,577

(842)

-

(842)

Assets (1a - 1b)

(d)

Deferred Tax Assets

-

-

-

-

-

-

-

-

-

Nonadmitted

(e)

Subtotal Net Admitted

2,735

-

2,735

3,577

-

3,577

(842)

-

(842)

Deferred Tax Asset (1c - 1d)

(f)

Deferred Tax Liabilities

2,735

-

2,735

3,577

-

3,577

(842)

-

(842)

(g)

Net Admitted Deferred Tax

Asset/(Net Deferred Tax

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

Liability)(1e-1f)

2.

Admission Calculation

6/30/2024

12/31/2023

Change

Components SSAP No. 101

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(Col 1+2)

(Col 4+5)

(Col 1-4)

(Col 2-5)

(Col 7+8)

Ordinary

Capital

Total

Ordinary

Capital

Total

Ordinary

Capital

Total

(a)

Federal Income Taxes Paid in

Prior Years Recoverable

Through Loss Carrybacks

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

(b)

Adjusted Gross Deferred Tax

Assets Expected To Be

Realized (Lesser of 2(b)1 and

2(b)2 Below)

$

2,735

$

-

$

2,735

$

3,577

$

-

$

3,577

$

(842)

$

-

$

(842)

1.

Adjusted Gross Deferred

Tax Assets Expected To

Be Realized Following the

$

2,735

$

-

$

2,735

$

3,577

$

-

$

3,577

$

(842)

$

-

$

(842)

Balance Sheet Date

2.

Adjusted Gross Deferred

Tax Assets Allowed per

XXX

XXX

$

750,000

XXX

XXX

$

750,000

XXX

XXX

$

-

Limitation Threshold

(c)

Adjusted Gross Deferred Tax

Assets Offset by Gross

Deferred Tax Liabilities

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

-

  1. Deferred Tax Assets Admitted as the result of application of

SSAP No. 101

$

2,735

$

- $

2,735

$

3,577

$

- $

3,577

$

(842)

$

- $

(842)

3. Ratio used as basis of admissibility

  1. Ratio Percentage Used To Determine Recovery Period And Threshold Limitation Amount
  2. Amount Of Adjusted Capital And Surplus Used To Determine Recovery Period And Threshold Limitation in 2(b)2 Above

6/30/2024

12/31/2023

485 %

485 %

$

5,000,000

$

5,000,000

4. Impact of tax-planning strategies

6/30/2024

12/31/2023

Change

(1)

(2)

(3)

(4)

(5)

(6)

(Col 1-3)

(Col 2-4)

Ordinary

Capital

Ordinary

Capital

Ordinary

Capital

  1. Determination Of Adjusted Gross Deferred Tax Assets And Net Admitted Deferred Tax Assets, By Tax Character As A Percentage.

1 Adjusted Gross DTAs Amount From Note 9A1(c)

$

2,735

$

- $

3,577

$

- $

(842)

$

-

2 Percentage Of Adjusted Gross DTAs By Tax Character Attributable To The Impact Of Tax Planning

Strategies

-

-

-

-

-

-

3

Net Admitted Adjusted Gross DTAs Amount From

2,735

-

3,577

-

(842)

-

Note 9A1(e)

4

Percentage Of Net Admitted Adjusted Gross DTAs By

Tax Character Admitted Because Of The Impact Of

-

-

-

-

-

-

Tax Planning Strategies

(b) Does the Company's tax-planning strategies include the use of reinsurance?

No

B. Deferred Tax Liabilities Not Recognized - None.

6.3

6WDWHPHQWDVRI-XQHRIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY

127(672),1$1&,$/67$7(0(176

C. Current income taxes consist of the following major components:

(1)

(2)

(3)

(Col 1-2)

6/30/2024

12/31/2023

Change

1.

Current Income Tax

(a)

Federal

$

-

$

-

$

-

(b)

Foreign

-

-

-

(c)

Subtotal (1a+1b)

-

-

-

(d)

Federal income tax on net capital gains

-

-

-

(e)

Utilization of capital loss carry-forwards

-

-

-

(f)

Other

-

18,808

(18,808)

(g)

Federal and foreign income taxes incurred (1c+1d+1e+1f)

$

-

$

18,808

$

(18,808)

2.

Deferred Tax Assets:

(a)

Ordinary

(1)

Discounting of unpaid losses

$

49,667

$

49,667

$

-

(2)

Unearned premium reserve

14,620

30,987

(16,367)

(3)

Policyholder reserves

-

-

-

(4)

Investments

-

-

-

(5)

Deferred acquisition costs

-

-

-

(6)

Policyholder dividends accrual

-

-

-

(7)

Fixed assets

-

-

-

(8)

Compensation and benefits accrual

-

-

-

(9)

Pension accrual

-

-

-

(10)

Receivables - nonadmitted

-

-

-

(11)

Net operating loss carry-forward

17,791

5,615

12,176

(12)

Tax credit carry-forward

-

-

-

(13)

Other

-

-

-

(99) Subtotal (sum of 2a1 through 2a13)

$

82,078

$

86,269

$

(4,191)

(b)

Statutory valuation allowance adjustment

79,343

82,692

(3,349)

(c)

Nonadmitted

-

-

-

(d)

Admitted ordinary deferred tax assets (2a99 - 2b - 2c)

$

2,735

$

3,577

$

(842)

(e)

Capital

(1)

Investments

$

-

$

-

$

-

(2)

Net capital loss carry-forward

-

-

-

(3)

Real estate

-

-

-

(4)

Other

-

-

-

(99) Subtotal (2e1+2e2+2e3+2e4)

$

-

$

-

$

-

(f)

Statutory valuation allowance adjustment

-

-

-

(g)

Nonadmitted

-

-

-

(h)

Admitted capital deferred tax assets (2e99 - 2f - 2g)

$

-

$

-

$

-

(i)

Admitted deferred tax assets (2d + 2h)

$

2,735

$

3,577

$

(842)

3.

Deferred Tax Liabilities:

(a)

Ordinary

(1)

Investments

$

-

$

-

$

-

(2)

Fixed assets

-

-

-

(3)

Deferred and uncollected premium

-

-

-

(4)

Policyholder reserves

-

-

-

(5)

Other

2,735

3,577

(842)

(99) Subtotal (3a1+3a2+3a3+3a4+3a5)

$

2,735

$

3,577

$

(842)

(b)

Capital

(1)

Investments

$

-

$

-

$

-

(2)

Real estate

-

-

-

(3)

Other

-

-

-

(99) Subtotal (3b1+3b2+3b3)

$

-

$

-

$

-

(c)

Deferred tax liabilities (3a99 + 3b99)

$

2,735

$

3,577

$

(842)

4.

Net deferred tax assets/liabilities (2i - 3c)

$

- $

- $

-

6.4

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

ProAssurance Corporation published this content on 16 August 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on August 16, 2024 at 14:57:49 UTC.

Older

"NORCAL Specialty Insurance Company","PNC QS","2024 06 30" Annual Statutory Statement

Newer

Equitable Financial Life Insurance Company – Second Quarter 2024

Advisor News

  • Market reports turn economic trends into a strategic edge for advisors
  • SEC in ‘active and detailed’ settlement talks with accused scammer Tai Lopez
  • Sketching out the golden years: new book tries to make retirement planning fun
  • Most women say they are their household’s CFO, Allianz Life survey finds
  • MassMutual reports strong 2025 results
More Advisor News

Annuity News

  • Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
  • Rethinking whether annuities are too late for older retirees
  • Advising clients wanting to retire early: how annuities can bridge the gap
  • F&G joins Voya’s annuity platform
  • Regulators ponder how to tamp down annuity illustrations as high as 27%
More Annuity News

Health/Employee Benefits News

  • PID finds violations by Aetna Insurance
  • Iowa insurance firms warn bill would make health costs rise
  • ELLMAN BILL PROTECTS ACCESS TO HEALTH COVERAGE, PREVENTS DENIALS OVER PAST-DUE PREMIUMS
  • Blue Cross Blue Shield of Wyoming CEO Gore announces retirement; Urbanek to take lead
  • Wellpoint taps Rachel Chinetti as president
More Health/Employee Benefits News

Life Insurance News

  • Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
  • LIMRA: Individual life insurance new premium sets 2025 sales record
  • How AI can drive and bridge the insurance skills gap
  • Symetra Partners With Empathy to Offer Bereavement Support to Group Life Insurance Beneficiaries
  • National Life Group Ranked Second by The Wall Street Journal in Best Whole Life Insurance Companies of 2026
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

Your Cap. Your Term. Locked.
Oceanview CapLock™. One locked cap. No annual re-declarations. Clear expectations from day one.

Ready to make your client presentations more engaging?
EnsightTM marketing stories, available with select Allianz Life Insurance Company of North America FIAs.

Press Releases

  • RFP #T25521
  • ICMG Announces 2026 Don Kampe Lifetime Achievement Award Recipient
  • RFP #T22521
  • Hexure Launches First Fully Digital NIGO Resubmission Workflow to Accelerate Time to Issue
  • RFP #T25221
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet